Multi-institutional survey of carotid body tumors in Japan

Ikeda,Aya; Shiga,Kiyoto; Katagiri,Katsunori; Saito,Daisuke; Miyaguchi,Jun; Oikawa,Shin‑Ichi; Tsuchida,Kodai; Asakage,Takahiro; Ozawa,Hiroyuki; Nibu,Ken‑Ichi; Ohtsuki,Naoki; Fujimoto,Yasushi; Kaneko,Ken‑Ichi

doi:10.3892/ol.2018.7925

Multi-institutional survey of carotid body tumors in Japan

Authors:
- Aya Ikeda
- Kiyoto Shiga
- Katsunori Katagiri
- Daisuke Saito
- Jun Miyaguchi
- Shin‑Ichi Oikawa
- Kodai Tsuchida
- Takahiro Asakage
- Hiroyuki Ozawa
- Ken‑Ichi Nibu
- Naoki Ohtsuki
- Yasushi Fujimoto
- Ken‑Ichi Kaneko
View Affiliations

Affiliations: Department of Head and Neck Surgery, Iwate Medical University School of Medicine, Morioka, Iwate 020‑8505, Japan, Department of Head and Neck Surgery, Tokyo Medical and Dental University School of Medicine, Tokyo 113‑8510, Japan, Department of Otorhinolaryngology‑Head and Neck Surgery, Keio University School of Medicine, Tokyo 160‑8582, Japan, Department of Otolaryngology‑Head and Neck Surgery, Kobe University School of Medicine, Kobe 650‑0017, Japan, Department of Otorhinolaryngology, Nagoya University Graduate School of Medicine, Nagoya 466‑8560, Japan, Department of Otolaryngology‑Head & Neck Surgery, Nagasaki University School of Medicine, Nagasaki 852‑8501, Japan
Published online on: February 2, 2018 https://doi.org/10.3892/ol.2018.7925
Pages: 5318-5324

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

There has been no attempt to clarify the status of patients with carotid body tumor (CBT) in Japan. This multi‑institutional survey analyzed patients with CBT throughout Japan by gathering information on these patients from institutions that performed head and neck surgeries. Information from a total of 150 patients from 25 institutions from the past 20 years was employed in the present survey. There were 87 females and 63 males, and their mean age was 48.0 years old. The most common chief complaint was a neck mass and the mean suffering period was 46.1 months. Eighteen patients had a family history of paragangliomas and fifteen patients had bilateral CBTs. Among the 94 patients who underwent surgery to remove a CBT, 23 patients had tumors classified as Shamblin type I, 59 had type II and 12 had type III. The most frequent feeding artery of these CBTs was the ascending pharyngeal artery. Preoperative embolization of these arteries was effective in reducing blood loss; however, the operation time in Shamblin type I and II tumors was not improved. Thus these results revealed the status of patients with CBT and their treatment throughout Japan.

View Figures

View References

1	Shamblin WR, ReMine WH, Sheps SG and Harrison EG Jr: Carotid body tumor (Chemodectoma), Clinicopathologic analysis of ninety cases. Am J Surg. 122:732–739. 1971. View Article : Google Scholar
2	Fruhmann J, Geigl JB, Konstantiniuk P and Cohnert TU: Paraganglioma of the carotid body: Treatment strategy and SDH-gene mutations. Eur Vasc Endovasc Surg. 45:431–436. 2013. View Article : Google Scholar
3	Sajid MS, Hamilton G and Baker DM: A multicenter review of carotid body tumor management. Eur J Vasc Endovasc Surg. 34:127–130. 2007. View Article : Google Scholar
4	Lee JH, Barich F, Karnell LH, Robinson RA, Zhen WK, Gantz BJ and Hoffman HT; American College of Surgeons Commission on Cancer, ; American Cancer Society, : National cancer data base report on malignant paragangliomas of the head and neck. Cancer. 94:730–737. 2002. View Article : Google Scholar
5	Zhang WC, Cheng JP, Li Q, Zhang L, Wang XD and Anniko M: Clinical and pathological analysis of malignant carotid body tumor: A report of nine cases. Acta Otolaryngol. 129:1320–1325. 2009. View Article : Google Scholar
6	Hall TC, Renwick P and Stafford ND: Recurrent familial malignant carotid body tumour presenting with lymph node metastasis: Case report and review of diagnosis and management of familial carotid body tumours. J Laryngol Otol. 124:1344–1346. 2010. View Article : Google Scholar
7	Nishijima H, Asakage T and Sugasawa M: Malignant carotid body tumor with systemic metastases. Ann Otol Rhinol Lalyngol. 120:381–385. 2011. View Article : Google Scholar
8	Offergeld C, Brase C, Yaremchuk S, Mader I, Rischke HC, Gläsker S, Schmid KW, Wiech T, Preuss SF, Suárez C, et al: Head and neck paragangliomas: Clinical and molecular genetic classification. Clinics(Sao Paulo). 67 Suppl 1:S19–S28. 2012. View Article : Google Scholar
9	Burnichon N, Rohmer V, Amar L, Herman P, Leboulleux S, Darrouzet V, Niccoli P, Gaillard D, Chabrier G, Chabolle F, et al: The succinate dehydrogenase genetic testing in a large prospective series of patients with Paragangliomas. J Clin Endocrinol Metab. 94:2817–2827. 2009. View Article : Google Scholar
10	Neumann HP, Erlic Z, Boedeker CC, Rybicki LA, Robleda M, Hermsen M, Schiavi F, Falcioni M, Kwok P, Bauters C, et al: Clinical predictors for germline mutations. in head and neck paraganglioma patients: Cost reduction strategy in genetic diagnostic process as fall-out. Cancer Res. 69:3650–3656. 2009. View Article : Google Scholar
11	Astuti D, Latif F, Dallolv A, Dahia PL, Douglas F, George E, Sköldberg F, Husebye ES, Eng C and Maher ER: Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet. 69:49–54. 2001. View Article : Google Scholar
12	Kirmani S and Young WF: Hereditary Paraganglioma-Pheochromocytoma Syndromes. Gene Reviews = Source GeneReviews^® [Internet]. Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mefford HC, Stephens K, Amemiya A and Ledbetter N: University of Washington; Seattle: 2008 Nov 6–2014
13	Unlü Y, Becit N, Ceviz M and Koçak H: Management of carotid body tumors and familial paragangliomas: Review of 30 years' experience. Ann Vasc Surg. 23:616–620. 2009. View Article : Google Scholar
14	O'Neill S, O'Donnell M, Harkin D, Loughrey M, Lee B and Blair P: A 22-year northern Irish experience of carotid body tumours. Ulster Med J. 80:133–140. 2011.
15	Nazari I, Moghaddam FA, Zamani MM and Salimi J: Clinical characteristics and remedies in 45 Iranians with carotid body tumors. Acta Med Iran. 50:339–343. 2012.
16	Luna-Ortiz K, Rascon-Ortiz M, Villavicencio-Valencia V, Granados-Garcia M and Herrera-Gomez A: Carotid body tumors: Review of a 20-year experience. Oral Oncol. 41:56–61. 2005. View Article : Google Scholar
17	Sridhara SK, Yener M, Hnna EY, Rich T, Jimenez C and Kupferman ME: Genetic testing in head and neck paraganglioma: Who, what and why? J Neurol Surg B Skull Base. 74:236–240. 2013. View Article : Google Scholar
18	Ogawa K, Shiga K, Saijo S, Ogawa T, Kimura N and Horii A: A novel G106D alteration of the SDHD gene in a pedigree with familial paraganglioma. Am J Med Genet A. 140:2441–2446. 2006. View Article : Google Scholar
19	Kim ES, Kim SY, Mo EY, Jang DK, Moon SD and Han JH: Novel germline SDHD mutation in a patient with recurrent familial carotid body tumor and concomitant pheochromocytoma. Head neck. 36:E131–E135. 2014. View Article : Google Scholar
20	Wang CP, Chen TC, Chang YL, Ko JY, Yang TL, Lo FY, Hu YL, Chen PL, Wu CC and Lou PJ: Common genetic mutations in the start codon of the SDH subunit D gene among Chinese families with familial head and neck paragangliomas. Oral Oncol. 48:125–129. 2012. View Article : Google Scholar
21	Kupferman ME and Hanna EY: Paragangliomas of the head and neck. Curr Oncol Rep. 10:156–161. 2008. View Article : Google Scholar
22	Power AH, Bower TC, Kasperbauer J, Link MJ, Oderich G, Cloft H, Young WF Jr and Gloviczki P: Impact of preoperative embolization on outcomes of carotid body tumor resections. J Vasc Surg. 56:979–989. 2012. View Article : Google Scholar
23	Torrealba JI, Valdés F, Krämer AH, Mertens R, Bergoeing M and Mariné L: Management of carotid bifurcation tumors: 30-year experience. Ann Vasc Surg. 34:200–205. 2016. View Article : Google Scholar